Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01910844
What this trial is testing

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes

Who this might be right for
Metastatic Breast Cancer
Centre Jean Perrin 3
Early research (Phase 1)Looking for participantsNCT05743621
What this trial is testing

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Weill Medical College of Cornell University 30
Early research (Phase 1)Active Not RecruitingNCT06895811
What this trial is testing

Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Shanghai Changzheng Hospital 3
Testing effectiveness (Phase 2)Study completedNCT00096499
What this trial is testing

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT04506567
What this trial is testing

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Study completedNCT03392428
What this trial is testing

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateMetastatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 201
Early research (Phase 1)Study completedNCT03123978
What this trial is testing

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
University of California, Davis 6
Testing effectiveness (Phase 2)UnknownNCT02177643
What this trial is testing

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Who this might be right for
Diabetes-Related ComplicationsDiabetes Mellitus, Type 2Insulin Resistance
University of Campinas, Brazil 60
Post-approval studies (Phase 4)Study completedNCT00434447
What this trial is testing

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Who this might be right for
Bone Neoplasms
Novartis Pharmaceuticals 73
Early research (Phase 1)Study completedNCT01385228
What this trial is testing

Pazopanib, Docetaxel, Prednisone Prostate

Who this might be right for
Prostate Cancer
Daniel George, MD 36
Testing effectiveness (Phase 2)Looking for participantsNCT06216249
What this trial is testing

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Who this might be right for
Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Jonsson Comprehensive Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT02512458
What this trial is testing

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

Who this might be right for
Bone Metastatic Prostate Cancer
Hellenic Cooperative Oncology Group 60
Early research (Phase 1)WithdrawnNCT05807126
What this trial is testing

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05479578
What this trial is testing

Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8
Rashmi Verma, MD 7
Testing effectiveness (Phase 2)Ended earlyNCT02964988
What this trial is testing

UPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticBone Metastases
Rigshospitalet, Denmark 17
Early research (Phase 1)Study completedNCT03076203
What this trial is testing

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneStage IV Prostate AdenocarcinomaHormone-refractory Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Very early researchNot Yet RecruitingNCT06546527
What this trial is testing

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Who this might be right for
Prostate Cancer
Peking University First Hospital 12
Early research (Phase 1)Temporarily pausedNCT05425862
What this trial is testing

Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05204927
What this trial is testing

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate
Curium US LLC 439
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Next Page